273 related articles for article (PubMed ID: 37301133)
1. Gut microbiota and metabolites in diabetic retinopathy: Insights into pathogenesis for novel therapeutic strategies.
Cai Y; Kang Y
Biomed Pharmacother; 2023 Aug; 164():114994. PubMed ID: 37301133
[TBL] [Abstract][Full Text] [Related]
2. Evidence Suggesting the Role of Gut Dysbiosis in Diabetic Retinopathy.
Thakur PS; Aggarwal D; Takkar B; Shivaji S; Das T
Invest Ophthalmol Vis Sci; 2022 Jul; 63(8):21. PubMed ID: 35877085
[TBL] [Abstract][Full Text] [Related]
3. The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy.
Zhang H; Mo Y
Front Endocrinol (Lausanne); 2023; 14():1205846. PubMed ID: 37469982
[TBL] [Abstract][Full Text] [Related]
4. Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy.
Jiao J; Yu H; Yao L; Li L; Yang X; Liu L
J Inflamm Res; 2021; 14():6929-6938. PubMed ID: 34938095
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota: A potential therapeutic target for management of diabetic retinopathy?
Alarcón Yempén RE; Venzel R; Paulino Campos MC; de Oliveira LP; Lins RVD; Pessoni AM; Fanaro GB; de Oliveira Souza A; Calaza KDC; de Brito Alves JL; Cavalcanti-Neto MP
Life Sci; 2021 Dec; 286():120060. PubMed ID: 34666038
[TBL] [Abstract][Full Text] [Related]
6. Research progress of diabetic retinopathy and gut microecology.
Wang R; Wang QY; Bai Y; Bi YG; Cai SJ
Front Microbiol; 2023; 14():1256878. PubMed ID: 37744925
[TBL] [Abstract][Full Text] [Related]
7. Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy.
Huang Y; Wang Z; Ma H; Ji S; Chen Z; Cui Z; Chen J; Tang S
Front Cell Infect Microbiol; 2021; 11():646348. PubMed ID: 33816351
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota and Complications of Type-2 Diabetes.
Iatcu CO; Steen A; Covasa M
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
[TBL] [Abstract][Full Text] [Related]
9. The role of lipopolysaccharides in diabetic retinopathy.
Qin X; Zou H
BMC Ophthalmol; 2022 Feb; 22(1):86. PubMed ID: 35193549
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy.
Das T; Jayasudha R; Chakravarthy S; Prashanthi GS; Bhargava A; Tyagi M; Rani PK; Pappuru RR; Sharma S; Shivaji S
Sci Rep; 2021 Feb; 11(1):2738. PubMed ID: 33531650
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota Dysbiosis in Diabetic Retinopathy-Current Knowledge and Future Therapeutic Targets.
Serban D; Dascalu AM; Arsene AL; Tribus LC; Vancea G; Pantea Stoian A; Costea DO; Tudosie MS; Stana D; Cristea BM; Nicolae VA; Tudor C; Costea AC; Comandasu M; Faur M; Tanasescu C
Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109497
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the mechanisms underlying the beneficial effect of Luo Tong formula on retinal function in diabetic rats via the "gut microbiota-inflammation-retina" axis.
Di S; Yao C; Qiao L; Li X; Pang B; Lin J; Wang J; Li M; Tong X
Chin Med; 2022 Dec; 17(1):133. PubMed ID: 36461068
[TBL] [Abstract][Full Text] [Related]
13. Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy.
Fernandes R; Viana SD; Nunes S; Reis F
Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1876-1897. PubMed ID: 30287404
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-150 (miR-150) and Diabetic Retinopathy: Is miR-150 Only a Biomarker or Does It Contribute to Disease Progression?
Ko GY; Yu F; Bayless KJ; Ko ML
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292956
[TBL] [Abstract][Full Text] [Related]
15. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
16. Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in
Beli E; Yan Y; Moldovan L; Vieira CP; Gao R; Duan Y; Prasad R; Bhatwadekar A; White FA; Townsend SD; Chan L; Ryan CN; Morton D; Moldovan EG; Chu FI; Oudit GY; Derendorf H; Adorini L; Wang XX; Evans-Molina C; Mirmira RG; Boulton ME; Yoder MC; Li Q; Levi M; Busik JV; Grant MB
Diabetes; 2018 Sep; 67(9):1867-1879. PubMed ID: 29712667
[TBL] [Abstract][Full Text] [Related]
17. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
[TBL] [Abstract][Full Text] [Related]
18. Retinal Cell Damage in Diabetic Retinopathy.
Zhou J; Chen B
Cells; 2023 May; 12(9):. PubMed ID: 37174742
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome and diabetic retinopathy.
Jabbehdari S; Sallam AB
Eur J Ophthalmol; 2022 Sep; 32(5):2494-2497. PubMed ID: 35266406
[TBL] [Abstract][Full Text] [Related]
20. Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetes.
Li L; Yang K; Li C; Zhang H; Yu H; Chen K; Yang X; Liu L
Front Immunol; 2022; 13():943325. PubMed ID: 36059453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
